JBM Healthcare Announces FY2021 Annual Results – MENAFN.COM

  • Date: 30-Jun-2021
  • Source: MENAFN
  • Sector:Healthcare
  • Country:Gulf
  • Who else needs to know?

JBM Healthcare Announces FY2021 Annual Results – MENAFN.COM

(MENAFN - ACN NewsWire)HONG KONG, June 29, 2021 - (ACN Newswire) - JBM (Healthcare) Limited ("JBM Healthcare" or the "Group"; Stock Code: 2161), a leading branded healthcare products marketer and distributor in Hong Kong, has announced today the first annual results of the Group after its spin-off listing on the Main Board of The Stock Exchange of Hong Kong Limited on 5 February 2021. Despite the unprecedented challenges due to the COVID-19 pandemic, the Group posted a total revenue of HK$397. 2 million during the year ended 31 March 2021 ("Reporting Period"), representing a growth of 4. 1% from last year. Before taking into account the one-off listing expenses, the adjusted net profit* increased by 13. 3% to HK$54. 6 million when compared with last year. Basic earnings per share was HK2. 78 cents. Resilient Performance Driven by Strong Product PortfolioJBM Healthcare carries a robust and broad portfolio of branded healthcare products in the segments of branded medicines, proprietary Chinese medicines, and health and wellness products. As for the proprietary Chinese medicines ("PCM") business, sales revenue notably increased by 14. 6% to HK$210. 9 million, driven by the buoyant performance of Hoitin concentrated Chinese medicine granules products, alongside a 16.